LATTANZIO, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 1.802
EU - Europa 1.239
AS - Asia 1.227
SA - Sud America 92
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.375
Nazione #
US - Stati Uniti d'America 1.766
SG - Singapore 458
CN - Cina 412
UA - Ucraina 216
TR - Turchia 192
IE - Irlanda 191
SE - Svezia 175
GB - Regno Unito 164
FR - Francia 159
DE - Germania 94
IT - Italia 90
BR - Brasile 80
IN - India 71
FI - Finlandia 70
VN - Vietnam 41
RU - Federazione Russa 37
CA - Canada 23
PL - Polonia 17
HK - Hong Kong 10
BD - Bangladesh 9
MX - Messico 8
ES - Italia 7
AT - Austria 6
IQ - Iraq 6
ZA - Sudafrica 6
AR - Argentina 5
BE - Belgio 4
ID - Indonesia 4
JP - Giappone 4
BZ - Belize 3
EU - Europa 3
MA - Marocco 3
NL - Olanda 3
CL - Cile 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
IL - Israele 2
KR - Corea 2
PK - Pakistan 2
QA - Qatar 2
RO - Romania 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
CO - Colombia 1
EG - Egitto 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MT - Malta 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.375
Città #
Singapore 358
Chandler 262
Jacksonville 257
Dublin 191
Beijing 132
Southend 132
Ashburn 127
Izmir 100
Dearborn 88
Princeton 85
Dallas 80
Nanjing 70
Santa Clara 60
Los Angeles 53
Wilmington 49
Cambridge 43
New York 41
The Dalles 39
Altamura 26
Tongling 25
Nanchang 24
Buffalo 21
Helsinki 19
Munich 18
Kunming 17
Boardman 15
Ho Chi Minh City 14
Washington 14
Hebei 13
Ann Arbor 12
Augusta 12
Montreal 12
Shenyang 12
Changsha 11
Jiaxing 11
Moscow 11
São Paulo 11
Warsaw 11
Woodbridge 11
Hong Kong 10
Brooklyn 9
Grevenbroich 8
Hanoi 8
Norwalk 8
Redondo Beach 8
San Mateo 8
Chieti 7
Hangzhou 7
Tianjin 7
Turku 7
Atlanta 6
Falls Church 6
London 6
Pescara 6
Seattle 6
Stockholm 6
Bexley 5
Boston 5
Chennai 5
Frankfurt am Main 5
Hefei 5
Vancouver 5
Ankara 4
Chicago 4
Denver 4
Jinan 4
Lanzhou 4
Manchester 4
Mountain View 4
Ningbo 4
Orem 4
Rome 4
Tappahannock 4
Tokyo 4
Toronto 4
Chongqing 3
Dong Ket 3
Erbil 3
Houston 3
Johannesburg 3
Milan 3
Phoenix 3
Poplar 3
Querétaro 3
Wroclaw 3
Baghdad 2
Boscotrecase 2
Cape Town 2
Cepagatti 2
Changchun 2
Chaoyang 2
Charlotte 2
Cleveland 2
Da Nang 2
Detroit 2
Diadema 2
Doha 2
Düsseldorf 2
Espera Feliz 2
Ghent 2
Totale 2.752
Nome #
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 157
Pentraxin 3 and platelet activation in obese patients after gastric banding 155
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 138
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 136
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 133
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 125
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 125
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 124
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 121
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 120
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 120
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 118
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 117
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 116
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 115
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 112
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 110
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 106
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 106
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 106
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 104
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 103
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 102
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 98
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 95
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 93
Endogenous secretory rage in obese women: association with oxidative stress and platelet activation. Proc. 112° Congr. Naz. Soc It. Med. Interna, Roma, ottobre 2011, Int Emerg Med 6(S2): S186, 2011 91
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 90
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 89
Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway 89
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation 87
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 87
Determinants of Platelet Activation in Heart Failure. 87
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 86
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype 85
Soluble CD40L as an indicator of platelet Activation in Heart Failure 83
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 83
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 82
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects. 80
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 79
Determinants of Platelet Activation in Heart Failure. 78
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 72
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype. 71
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 62
Totale 4.536
Categoria #
all - tutte 17.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021166 0 0 0 0 0 59 6 8 42 43 3 5
2021/2022209 3 7 2 58 20 6 2 14 17 10 22 48
2022/2023655 46 97 46 67 64 127 33 45 101 7 9 13
2023/2024319 29 10 22 7 19 97 73 11 14 4 4 29
2024/2025836 53 176 148 15 19 35 12 17 61 21 123 156
2025/2026763 132 69 132 194 218 18 0 0 0 0 0 0
Totale 4.536